MEDICO vs SIGACHI: Stock Comparison

Medico Remedies Limited vs Sigachi Industries Limited

Live data: 22 July 2026, 2:57 PM IST • Source: NSE and company filings

Sigachi Industries Limited is the larger company by market capitalisation. Medico Remedies Limited shows a higher ROE, faster revenue growth and lower leverage, while Sigachi Industries Limited shows a lower P/E and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Medico Remedies Limited and Sigachi Industries Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, MEDICO is more favourable on 10 of 13 scored metrics and SIGACHI on 3These counts are context-free and are not an overall rating.

Key Differences

Market Cap
SIGACHI is the larger company
₹1,011 Cr vs ₹317 Cr
P/E Ratio
SIGACHI has a lower P/E
-12.13x vs 27.22x
P/B Ratio
SIGACHI has a lower P/B
1.9x vs 4.73x
EPS
MEDICO has higher earnings per share
₹1.58 vs ₹-1.46
Dividend Yield
SIGACHI has a higher dividend yield
0.45% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 16.22%
EPS Growth (TTM YoY)
MEDICO has faster EPS growth
36.5% vs 0%
Qtr Sales Growth
MEDICO has stronger quarterly sales growth
37.6% vs -11.6%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricMEDICOSIGACHI
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricMEDICOSIGACHI
Live Price₹38.38₹21.03
Day Change-0.62%-4.23%
Volume16,59732.76 L
52-Week High₹56.88₹46.73
52-Week Low₹30.22₹16.65
Distance from 52W High-32.52%-55%

Valuation

MetricMEDICOSIGACHI
Market Cap₹317 Cr₹1,011 Cr
P/E Ratio27.22x-12.13x
P/B Ratio4.73x1.9x
EPS₹1.58₹-1.46
Book Value₹9.15₹15.72
Dividend Yield0%0.45%

Growth

MetricMEDICOSIGACHI
Revenue Growth (TTM YoY)37.5%16.22%
EPS Growth (TTM YoY)36.5%0%
Qtr Sales Growth37.6%-11.6%
Qtr Profit Growth35%-70.9%

Profitability & Leverage

MetricMEDICOSIGACHI
ROE19%-15.66%
ROCE23.1%15.5%
Net Margin6.36%-17.33%
Operating Margin8.25%-15.44%
Debt to Equity0.25x0.26x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricMEDICOSIGACHI
Promoter Holding61.38%36.69% 3.01 pp
FII Holding0.03% 0.46 pp1.3% 2.03 pp
DII Holding0%0%
Public Holding38.59% 0.46 pp62.01% 5.04 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Medico Remedies Limited and Sigachi Industries Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.